Altamira Therapeutics Ltd. Secures Japanese Patent...
Category : Product Related Updates 17 February 2026Altamira Therapeutics announced that its associate company, Altamira Medica, has received a notice o...
Altamira Therapeutics announced that its associate company, Altamira Medica, has received a notice o...
New real-world research presented at the AAAAI Annual Meeting suggests that glucagon-like peptide-1...
NuLiv Science has released results from a new preclinical study evaluating AstraGin®, its patent...
AskBio Inc., a gene therapy company wholly owned by Bayer AG, has received US FDA acceptance for its...
Ascletis Pharma has received FDA IND clearance to begin a Phase II study of ASC30 in type 2 diabetes...